Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry.
about
Stable isotope-resolved metabolomics and applications for drug developmentNew Technologies for Studying BiofilmsMass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition researchMetabolomics analysis reveals large effects of gut microflora on mammalian blood metabolitesHigh-precision frequency measurements: indispensable tools at the core of the molecular-level analysis of complex systems.Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum.Dealing with the unknown: metabolomics and metabolite atlases.Plasma metabolome analysis by integrated ionization rapid-resolution liquid chromatography/tandem mass spectrometry.Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data.Construction of confidence regions for isotopic abundance patterns in LC/MS data sets for rigorous determination of molecular formulas.Quantitating metabolites in protein precipitated serum using NMR spectroscopyMetabolomics of bronchoalveolar lavage differentiate healthy HIV-1-infected subjects from controls.Metabolic profiling of Escherichia coli by ion mobility-mass spectrometry with MALDI ion sourceChallenges in applying chemometrics to LC-MS-based global metabolite profile data.Diamond nanowires for highly sensitive matrix-free mass spectrometry analysis of small molecules.Global proteomics and metabolomics in cancer biomarker discovery.Meta-analysis of untargeted metabolomic data from multiple profiling experiments.Mass spectrometry-based metabolomics, analysis of metabolite-protein interactions, and imaging.High-resolution extracted ion chromatography, a new tool for metabolomics and lipidomics using a second-generation orbitrap mass spectrometer.Metabolic Profiling of Human Blood by High Resolution Ion Mobility Mass Spectrometry (IM-MS).Multi-step preparation technique to recover multiple metabolite compound classes for in-depth and informative metabolomic analysis.Phosphonium labeling for increasing metabolomic coverage of neutral lipids using electrospray ionization mass spectrometryA practical approach to detect unique metabolic patterns for personalized medicineExpanding the limits of human blood metabolite quantitation using NMR spectroscopy.Stable isotope-labeled tracers for metabolic pathway elucidation by GC-MS and FT-MS.Surface-assisted laser desorption/ionization mass spectrometry using ordered silicon nanopillar arrays.Evaluation of human plasma sample preparation protocols for untargeted metabolic profiles analyzed by UHPLC-ESI-TOF-MS.Extraction parameters for metabolomics from cultured cells.Metabolomics in the developmental origins of obesity and its cardiometabolic consequences.Impact of storage conditions on metabolite profiles of sputum samples from persons with cystic fibrosisEffects of pre-analytical processes on blood samples used in metabolomics studies.Can we trust untargeted metabolomics? Results of the metabo-ring initiative, a large-scale, multi-instrument inter-laboratory study.Mobilization of pro-inflammatory lipids in obese Plscr3-deficient miceClass selection of amino acid metabolites in body fluids using chemical derivatization and their enhanced 13C NMR.High-performance metabolic profiling with dual chromatography-Fourier-transform mass spectrometry (DC-FTMS) for study of the exposome.Analysis of human plasma metabolites across different liquid chromatography/mass spectrometry platforms: Cross-platform transferable chemical signatures.Systematic evaluation of extraction methods for multiplatform-based metabotyping: application to the Fasciola hepatica metabolomeA mass spectrometric study for comparative analysis and evaluation of metabolite recovery from plasma by various solvent systems.Relative quantification of biomarkers using mixed-isotope labeling coupled with MS.Metabolic profiling technologies for biomarker discovery in biomedicine and drug development.
P2860
Q24629149-5A3A68AC-DB61-473C-A678-FC505077716FQ26782595-054E33C1-848F-456A-A596-A953EB5FBCBFQ29014502-8058F861-C985-4CEA-9D72-8CBD0492BFEAQ29619788-81F88020-09DE-4B6F-A449-D9B1D6440363Q30481371-8F99815F-4774-42B5-B4A8-B4736C3B4419Q31040233-96D1112A-DBC8-4639-AE31-8CE5CA2C5988Q33349044-5F529C70-A9E3-42FF-969E-0BFB8FD3D457Q33458909-AFAC95E2-C0EB-481D-BF14-B500AB672C4BQ33504770-685F89F1-5468-4B9A-9009-3B4C6ED458A6Q33651403-BA603629-3378-4101-9DC0-B68862DCA5CDQ33710486-16CFAFBB-455C-4973-A51A-F6B0D08910FEQ33713799-67041C36-2EAC-47B8-BF13-E2C5A1B31F8CQ33725838-61BAA0DE-68CE-4045-80ED-94A804013EC2Q33748851-DC4E03AB-8519-427C-8E52-D3517DAA559EQ34073592-3627AF14-1360-4B6A-A387-1A1557A20685Q34079038-417B60A6-7CD5-47BA-B144-EA1BCF314E47Q34161462-4A7CC4BA-33F3-475E-8D42-4E2921A7C46BQ34255736-B92C0B78-3949-4C25-841C-3128BEBBE124Q34269278-D6C1DA76-4657-403C-A9F8-97670EDEFA0AQ34344528-786D53DA-3AC7-44FE-97A8-E6370B4DAF1BQ34426998-0C256091-5E3A-4684-8864-82F23F83B69CQ34639450-F1DA7FB9-A605-4F09-A4C0-BE441FAE56F5Q34754691-5EA64A56-13A9-4A76-B1C5-35CE166D2524Q34879047-8994D9BF-5A3A-4E17-A678-2B13AA51B674Q35109445-7C33DA07-5604-40D5-9132-2A396A479135Q35288599-0AE8D9AB-8767-4C1C-8895-2FACB84A9736Q35325207-F3A52A51-6242-4821-8FE3-CF21973DE6A4Q35417839-8CDA822B-3B12-47CA-B480-963FF8BCC65BQ35525760-9B7AF265-5F7D-4E85-9858-F09F67BC7C22Q35569460-15419AA5-F992-4092-B0B8-BDF241315B9BQ35753268-63A9E380-8311-4C56-B27B-35DE2627DADBQ35763105-C6DF4E02-2E10-4241-A43B-6EAD6FD6BFACQ35794422-802C2BFC-F83C-45EC-AD7F-69AEFCD44E82Q35880308-38FCF2EC-6D81-494E-992E-200D9BB46B15Q35895828-D6E8D3B0-2671-40B8-BE78-BDE8D45E74DBQ35913892-AE636E53-FE6B-4C4A-B1F9-C83E2354B3A4Q36178055-95476C4D-12C3-4D9E-A1C4-B149FDF56570Q36221553-BB5EAEE5-52AB-4710-9A4E-B486500E5A8BQ36617725-1882F0A9-6A34-4651-B8EE-55715F6CCB1EQ36629997-571DFB24-F940-4227-88B1-0C209EA198B6
P2860
Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Solvent-dependent metabolite d ...... filing with mass spectrometry.
@en
Solvent-dependent metabolite d ...... filing with mass spectrometry.
@nl
type
label
Solvent-dependent metabolite d ...... filing with mass spectrometry.
@en
Solvent-dependent metabolite d ...... filing with mass spectrometry.
@nl
prefLabel
Solvent-dependent metabolite d ...... filing with mass spectrometry.
@en
Solvent-dependent metabolite d ...... filing with mass spectrometry.
@nl
P2093
P356
P1433
P1476
Solvent-dependent metabolite d ...... filing with mass spectrometry.
@en
P2093
Elizabeth J Want
Grace O'Maille
Sunia A Trauger
Theodore R Brandon
Wilasinee Uritboonthai
P304
P356
10.1021/AC051312T
P407
P577
2006-02-01T00:00:00Z